Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001387131-20-003861
Filing Date
2020-04-13
Accepted
2020-04-13 17:16:07
Documents
7
Period of Report
2020-06-18

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT txmd-pre14a_061820.htm PRE 14A 833321
2 GRAPHIC txmdpre14a061820001.jpg GRAPHIC 8664
3 GRAPHIC txmdpre14a061820002.jpg GRAPHIC 8196
4 GRAPHIC txmd-pre14a001.jpg GRAPHIC 2529
5 GRAPHIC txmd-pre14a002.jpg GRAPHIC 2057
6 GRAPHIC txmdpre14a-001.gif GRAPHIC 121362
7 GRAPHIC txmdpre14-002.gif GRAPHIC 113630
  Complete submission text file 0001387131-20-003861.txt   1188501
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-00100 | Film No.: 20789358
SIC: 2834 Pharmaceutical Preparations